Psychiatric Quarterly

, Volume 78, Issue 3, pp 219–235 | Cite as

A Neuropsychiatry Service in a State Hospital. Adolf Meyer’s Approach Revisited

Review Article


In the spirit of Adolf Mayer’s medico-biological approach to the understanding of mental illnesses the article describes the advantages that neuropsychiatric approach brings to the diagnostic evaluation and treatment of psychiatric patients in a state hospital. Our review discusses the neuropsychiatric approach to the evaluation of state hospital patients with mild, moderate, and severe cognitive disturbances showing the role of neuropsychological testing, electroencephalography (EEG), and brain imaging in the neuropsychiatric assessment of primary and secondary mental illnesses. Neuropsychiatric evaluation helps to assess the peculiarities of movement disorder as a of side effects of regular psychiatric medications, e.g. the differences in diagnostic signs and treatment implication between Parkinson’s disease and exrapyramidal syndrome (EPS) as a side effect of neuroleptics as well as the development of abnormal reflexes as a sign of tardive dyskinesia (TD) not directly related to the lesion of upper motor neuron. The article also discusses the development of hypokinetic delirium in the course of treatment of psychiatric patients not only as a side effect of neuroleptics but also of anticonvulsants, increasingly used as the mood stabilizers in modern psychiatry. Since aggressive behavior of psychiatric patients represents one of the major criteria for admission and often long term treatment in a state hospital, special consideration is given to the role of brain paroxysmal activity in the development of aggressive behavior, especially rage attacks, one of the main manifestations of aggressive behavior in a state hospital patients. Correspondingly, the use of anticonvulsants in the treatment of rage attacks is discussed. This article may serve as a model for the use of neuropsychiatric service in improvement of diagnostic evaluation and treatment of psychiatric patients in a state hospital.


Neuropsychiatry Service Cognition Seizures Movement Disorder 


  1. 1.
    Sabshin M: Turning points in twentieth-century American psychiatry. American Journal of Psychiatry 147:1267–1274, 1990.PubMedGoogle Scholar
  2. 2.
    Meyer A: The anatomical facts and clinical varieties of traumatic insanity. American Journal of Insanity 60:373–441, 1904.Google Scholar
  3. 3.
    Folstein MF, Folstein SE, Mchugh PR: Mini-Mental State; a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12:189–198, 1975.PubMedCrossRefGoogle Scholar
  4. 4.
    Tonkonogy J: The Brief Neuropsychological Cognitive Examination, Los Angeles, Western Psychological Services, 1997.Google Scholar
  5. 5.
    Weinberger DR, Torrey EF, Neophytides AN, et al.: Lateral ventricular enlargement in chronic schizophrenia. Archives of General Psychiatry 36:735–739, 1979.PubMedGoogle Scholar
  6. 6.
    Andreasen NC, Smith MR, Jacoby CG, et al.: Ventricular enlargement in schizophrenia; definition and prevalence. American Journal of Psychiatry 139:292–296, 1982.PubMedGoogle Scholar
  7. 7.
    Pandarangi AK, Dewan MJ, Lee SH, et al.: The ventricular system in chronic schizophrenic patients, a controlled tomographic study. British Journal of Psychiatry 144:172–176, 1984.Google Scholar
  8. 8.
    Nasrallah HA, Jacoby CG, Mccalley-Witer M, et al.: Cerebral ventricular enlargement in subtypes of chronic schizophrenia. Arch Gen Psychiatry 39:774–779, 1982.PubMedGoogle Scholar
  9. 9.
    Pearlson GD, Garbacz DJ, Breakey WR, et al.: Lateral ventricular enlargement associated with persistent unemployment and negative symptoms in both schizophrenia and bipolar disorder. Psychiatry Research 12:1–9, 1984.PubMedCrossRefGoogle Scholar
  10. 10.
    Lunchins DJ, Lewine RJ, Melzer HY: Lateral ventricular size, psychopathology, and medication responsein the psychosis. Biological Psychiatry 19:29–34, 1984.Google Scholar
  11. 11.
    Weinberger DR: Implication of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660–669, 1987.PubMedGoogle Scholar
  12. 12.
    Andreasen NC: Nuclear magnetic resonance imaging. In: Andreasen NC (Ed) Brain Imaging. Applications in Psychiatry, Washington, DC, American Psychiatric Press, pp 67–121, 1989.Google Scholar
  13. 13.
    Bersani G, Quartini A, Piperopoulos O, et al.: Brain abnormalities in schizophrenia. A qualitative comparative study pf schizophrenia patients and controls individuals. Journal de Neuroradiologie 33(3):152–157, 2006.PubMedGoogle Scholar
  14. 14.
    Nopoulos P, Torres I, Flaum M, et al.: Brain morphology in first episode schizophrenia. Am J Psychiatry 152:1721–1723, 1995.PubMedGoogle Scholar
  15. 15.
    Mathalon DH, Sullivan IV, Lim OK, et al.: Progressive brain volume changes and the clinical course of schizophrenia in men. Arch Gen Psychiatry 58:148–157, 2001.PubMedCrossRefGoogle Scholar
  16. 16.
    Byne W, Buchsbaum MS, Kemether E, et al.: Magnetic resonance imaging of the thalamic mediobasal nucleus and pulivinar in schizophrenia and schizotypical personality disorder Arch Gen Psychiatry 58:133–140, 2001.PubMedCrossRefGoogle Scholar
  17. 17.
    Lang DJ, Khorram B, Goghari VM, et al.: Reduced anterior internal capsule and thalamic volume in first-episode psychosis. Schizophrenia Research 87(1–3):89–99, 2006.PubMedCrossRefGoogle Scholar
  18. 18.
    Wright IC, Rabe-Hesketh S, Woodroof PW, et al.: Meta-analysis of regional brain volume in schizophrenia. Am J Psychiatry 157:16–25, 2000.PubMedGoogle Scholar
  19. 19.
    Davis KL, Stewart DG, Friedman JI, et al.: White matter changes in schizophrenia. Arch Gen Psychiatry 60:443–456, 2003.PubMedCrossRefGoogle Scholar
  20. 20.
    Kubicki M, Mccarley R, Westin CF, et al.: A review of diffuse tension imaging studies in schizophrenia. Journal of Psychiatric Research 411(1–2):15–30, 2007.CrossRefGoogle Scholar
  21. 21.
    Tonkonogy J, Head CT: MRI findings in 241 state hospital patients. Journal of Neuropsychiatry and Clinical Neuroscience 9:132–133, 1997.Google Scholar
  22. 22.
    Tonkonogy JM, Smith TW, Barreira PJ: Obsessive-Compulsive disorders in Pick’s disease. Journal of Neuropsychiatry and Clinical Neuroscience 6:176–180, 1994.Google Scholar
  23. 23.
    Fazekas F, Chawluk JB, Alavi A, et al.: MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. American Journal of Neuroradiology 8:421–426, 1987.Google Scholar
  24. 24.
    Miller BL, Lesser IM, Boone K, et al.: Brain white matter lesion and psychosis. British Journal of Psychiatry 155:73–78, 1989.PubMedCrossRefGoogle Scholar
  25. 25.
    Breitner JCS, Husain MM, Figel GS, et al.: Cerebral white matter disease in late-onset paranoid psychosis. Biological Psychiatry 28:266–274, 1993.CrossRefGoogle Scholar
  26. 26.
    Tonkonogy J, Geller J: Late-onset paranoid psychosis as distinct clinicopathological entity: magnetic resonance imaging data in elderly patients with paranoid psychosis of late onset and schizophrenia of early onset. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 12:230–235, 1999.PubMedGoogle Scholar
  27. 27.
    Coffey CE, Fiegel GS, Djang WT, et al.: Leukoenecephalopathy in elderly depressed patients referred for ECT. Biological Psychiatry 24:143–161, 1988.PubMedCrossRefGoogle Scholar
  28. 28.
    O’brien JT, Desmond P, Ames D, et al.: A magnetic resonance imaging study of white matter lesion in depression and Alzheimer’s disease. British Journal of Psychiatry 168:477–485, 1996.PubMedGoogle Scholar
  29. 29.
    Lesser IM, Miller BL, Boone KB, et al.: Brain and cognitive function in late onset psychotic depression. Journal of Neuropsychiatry and Clinical Neurosciences 3:33–40, 1991.PubMedGoogle Scholar
  30. 30.
    Tonkonogy J, Geller J: Hypothalamic lesion and intermittent explosive behavior. Journal of Neuropsychiatry and Clinical Neuroscience 1:169–174, 1992.Google Scholar
  31. 31.
    Leestma JE: Sudden unexpected death associated with seizures a pathological review. In: Lathers CM, Schraeder PL (Eds) Epilepsy and Sudden Death, Marcel Dekker, New York, pp 61–88, 1990.Google Scholar
  32. 32.
    Bach -Y-Rita G, Lion JR, Clement CE, et al.: Episodic dyscontrol: a study of 130 violent patients. American Journal of Psychiatry 127:1473–2478, 1971.PubMedGoogle Scholar
  33. 33.
    Maletzky BM: The episodic dyscontrol syndrome. Diseases of the Nervous System 34:186–189, 1973.Google Scholar
  34. 34.
    Elliot FA: Neurological findings in adult minimal brain dysfunction and the dyscontrol syndrome. Journal of Nervous and Mental Diseases 170:680–687, 1982.CrossRefGoogle Scholar
  35. 35.
    Lewis DO, Pincus JH, Shanok SS, et al.: Psychomotor epilepsy and violence in a group of incarcerated adolescent boys. American Journal of Psychiatry 139:882–887, 1982.PubMedGoogle Scholar
  36. 36.
    Bear DM: Temporal lobe epilepsy—a syndrome of sensory-limbic hyperconnection. Cortex 15:357–384, 1979.PubMedGoogle Scholar
  37. 37.
    Devinsky O, Bear D: Varieties of aggressive behavior in temporal lobe epilepsy. American Journal of Psychiatry 141:651–656, 1984.PubMedGoogle Scholar
  38. 38.
    Devinsky O, Ronsavo DE, Cox C, et al.: Interictal aggression in epilepsy: the Buss-Durke hostility inventory. Epilepsia 35:585–590, 1994.PubMedCrossRefGoogle Scholar
  39. 39.
    Hermann B, Riel P: Interictal personality and behavioral traits in temporal lobe and generalized epilepsy. Cortex 17:125–128, 1981.PubMedGoogle Scholar
  40. 40.
    Tardiff K: A survey of assault by chronic patients in a state hospital system, In: Lion J, Reid WH (Eds) Assault within Psychiatric Facility. New York, Grune and Stratton, pp 3–19, 1983.Google Scholar
  41. 41.
    Bhanji SG, Dubeau F, Andermann F, et al.: Psychiatric aspects of patients with hypothalamic hamartoma and epilepsy. Epileptic Disorders, 5(4):229–234, 2003.PubMedGoogle Scholar
  42. 42.
    Eslinger PJ, Grattan LM, Damasio H, et al.: Developmental consequences of childhood frontal lobe damage. Archives of Neurology 49:764–769, 1992.PubMedGoogle Scholar
  43. 43.
    Benjamin S: A neuropsychiatric approach to aggressive behavior, In: Ovsiew F (Ed) Neuropsychiatry and Mental Health Service. Washington, DC, American Psychiatric Press, pp 149–196, 1999.Google Scholar
  44. 44.
    Mcelroy SL: Recognition and treatment of DSM-IV intermittent explosive disorder. J Clin Psychiatry 15:12–6, 1999.Google Scholar
  45. 45.
    Mark VH, Ervin FR: Violence and the Brain. New York, Harper and Row, 1970.Google Scholar
  46. 46.
    Heat RJ: The neural basis for violent behavior: physiology and anatomy. In: Valzelli I, Margese I (Eds) Aggression and Violence: A Psycho-Biological and Clinical Approach. Milan, Italy, Edizioni Saint Vincent, pp. 176–194, 1980.Google Scholar
  47. 47.
    Saint-Hilaire JM, Gilibert M, Bonner G: Aggression as epileptic manifestation: two cases with depth electrodes. Epilepsia 21:184, 1980.Google Scholar
  48. 48.
    Silver JM, Yudofsky S, Anderson KE: Agitation and aggression In: Coffey CE, McAllister TW, Silver JM (Eds) Guide to Neuropsychiatric Therapeutics, Lippincott Williams and Wilkins, Philadelphia, pp.371–387, 2007.Google Scholar
  49. 49.
    Golden RN, Gilmore JH, Corrigan MHN, et al.: Serotonin, suicide, and aggression: clinical studies. Journal of Clinical Psychiatry 52:61–69, 1991.PubMedGoogle Scholar
  50. 50.
    Virkkunen M, Linnoila M: Brain serotonin, type II alcoholism, and impulsive violence. Journal for Studies of Alcoholism, Supplement 11:163–169, 1993.Google Scholar
  51. 51.
    Tonkonogy J, Gaulin B: Anticonvulsants and behavior control in state hospital patients. Hospital and Community Psychiatry Newsletter, pp 62–63, 1992.Google Scholar
  52. 52.
    Hamer HM, Knake S, Schomburg U, et al.: Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology 54:230–232, 2000.PubMedCrossRefGoogle Scholar
  53. 53.
    Mattes JA: Comparative effectivness of carbamazepine and propranolol for rage outbursts. J Neuropsychiatry Clin Neurosci 2(2):159–164, 1990.PubMedGoogle Scholar
  54. 54.
    Fisher W, Kroll G, Matthews D, et al.: Youth with impulsive aggression: anticonvulsant medications, compliance and outcome for 2005–2006. In Proceedings of the Annual meeting of the American Neuropsychiatric Association, Tucson, 2007, p.12.Google Scholar
  55. 55.
    Bazemore PH, Tonkonogy J. Annate R: Dysphasia in psychiatric patients: clinical and videofluoroscopic study. Dysphagia 6:2–5, 1991.PubMedCrossRefGoogle Scholar
  56. 56.
    Youseff HA, Waddington JL: Primitive (developmental reflexes) and diffuse cerebral dysfunction inschizophrenia and bipolar affective disorder: overrepresentation in patients with tardive dyskinesia. Biol Psychiatry 23:791–796, 1988.CrossRefGoogle Scholar
  57. 57.
    King DJ, Wilson A, Cooper SJ, et al.: The clinical correlates of neurological soft signs in chronic schizophrenia. Br J Psychiatry 158:770–775, 1991.PubMedCrossRefGoogle Scholar
  58. 58.
    Candela SF, Manschreck TC: NSS in schizophrenia. Research findings and clinical relevance. Psychiatric Annals 33(3):157–166, 2003.Google Scholar
  59. 59.
    Schroder J: Soft signs, neuroleptic side effects, and schizophrenia. Psychiatric Annals 33(3):215–220, 2003.Google Scholar
  60. 60.
    Meyer A: A short sketch of the problems of psychiatry. American Journal of Insanity 53:533–549, 1897.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Neuropsychiatry Service, Department of PsychiatryWorcester State Hospital, University of Massachusetts Medical SchoolWorcesterUSA
  2. 2.Public Psychiatry Division, Department of PsychiatryUniversity of Massachusetts Medical SchoolWorcesterUSA
  3. 3.WorcesterUSA

Personalised recommendations